扶正清肺化痰法治疗老年肺部感染临床观察.docVIP

扶正清肺化痰法治疗老年肺部感染临床观察.doc

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
扶正清肺化痰法治疗老年肺部感染临床观察

扶正清肺化痰法治疗老年肺部感染临床观察   [摘要] 目的 研究扶正清肺化痰法治疗老年肺部感染的临床疗效。 方法 选取我院2011年4月~2013年1月收治的80例肺部感染的老年患者为研究对象,随机分为两组,每组40例。对照组采取常规西医治疗,观察组在对照组的基础上加服扶正清肺化痰汤,比较两组临床疗效、治疗前后肺功能参数变化及治疗安全性。 结果 治疗后观察组的TLC、VC为(58.11±12.31)dL、(66.24±13.11)dL,高于对照组的(56.13±11.48)dL、(62.47±11.78)dL,但差异无统计学意义(P0.05);观察组的DLCO为(65.17±10.41)mmHg,高于对照组的(55.87±12.16)mmHg,差异具有统计学意义(P0.05)。观察组治疗的总有效率为95.0%,高于对照组的80.0%,差异具有统计学意义(P0.05)。两组均未见明显不良反应,肝肾功能、血尿常规检查均无异常。 结论 扶正清肺化痰法治疗老年肺部感染效果显著,能够提高患者的治愈率,降低病死率,改善肺功能,提高患者生活质量。   [关键词] 扶正清肺化痰法;肺部感染;老年患者;DLCO   [中图分类号] R259 [文献标识码] B [文章编号] 1673-9701(2015)35-0124-03   [Abstract] Objective To study the clinical curative effect of Fuzheng Qingfei Huatan method in the treatment of elderly pulmonary infection. Methods A total of 80 elderly patients with pulmonary infection who were admitted into the hospital during April 2011 to January 2013 were selected as the research objects, and were randomly divided into two groups with 40 cases in each group. The control group was treated with conventional western medicine, while the observation group on the basis of the control group, was additionally treated with Fuzheng Qingfei Huatan Decoction. The clinical efficacy and changes of pulmonary function parameters before and after the treatment was compared between the two groups. Results After the treatment, TLC and VC in the observation group was(58.11±12.31)dL and(66.24±13.11)dL, which was significantly higher than (56.13±11.48)dL and (62.47±11.78)dL in the control group, but the difference was not statistically significant (P0.05). DLCO(65.17±10.41)mmHg in the observation group, was higher than (55.87±12.16)mmHg in the control group, and the difference was statistically significant (P0.05). The total effective rate of the observation group was 95.0% which was higher than 80.0% of the control group and the difference was statistically significant(P0.05) No obvious adverse reactions were found in two groups, the liver and kidney function, and the routine examination of blood and uri

文档评论(0)

151****1926 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档